Private company

VIVEVE MEDICAL, INC.

VIVEVE MEDICAL, INC. is an American electromedical and electrotherapeutic apparatus company.1 It is headquartered in Englewood, Colorado.1

Last updated Oct 20, 2026.

Overview

  • IndustryElectromedical & Electrotherapeutic Apparatus1
  • HeadquartersEnglewood, Colorado1
  • Incorporated inDE2
  • Business address345 Inverness Drive South, Building B, Suite 250, Englewood, Co 801122
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

9.6%Gross margin3
-335.4%Operating margin3
-342.8%Net margin3
17.3%Revenue growth, 20213
-146.2%Return on equity3
-$13.3MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Cost of revenue20¢$5.8M
  • Research and development33¢$9.7M
  • Selling, general and admin43¢$12.5M
  • Interest3¢$1.0M

Out of $6.4M in revenue.3 The company lost money this year.

Financial statements

Revenue456783$6.4M in 2021+344% since 2015
0$5.0M$10.0M$15.0M$20.0M2015: $1.4M$1.4M20152016: $7.1M$7.1M2016+394%2017: $15.3M$15.3M2017+114%2018: $18.5M$18.5M2018+21%2019: $6.6M$6.6M2019−65%2020: $5.5M$5.5M2020−17%2021: $6.4M$6.4M2021+17%
Gross profit456783$620.0K in 2021+34% since 2015
0$2.0M$4.0M$6.0M$8.0M2015: $462.0K$462.0K20152016: $2.5M$2.5M2016+447%2017: $7.4M$7.4M2017+194%2018: $7.3M$7.3M2018−2%2019: $1.0M$1.0M2019−86%2020: $296.0K$296.0K2020−71%2021: $620.0K$620.0K2021+109%
Operating income456783-$21.6M in 2021+80% since 2015
-$60.0M-$40.0M-$20.0M02015: -$12.0M-$12.0M20152016: -$18.7M-$18.7M2016+56%2017: -$33.7M-$33.7M2017+80%2018: -$45.0M-$45.0M2018+33%2019: -$30.7M-$30.7M2019−32%2020: -$18.5M-$18.5M2020−40%2021: -$21.6M-$21.6M2021+17%
Net income456783-$22.0M in 2021+77% since 2015
-$60.0M-$40.0M-$20.0M02015: -$12.4M-$12.4M20152016: -$20.1M-$20.1M2016+62%2017: -$37.0M-$37.0M2017+84%2018: -$50.0M-$50.0M2018+35%2019: -$42.5M-$42.5M2019−15%2020: -$21.9M-$21.9M2020−48%2021: -$22.0M-$22.0M2021+1%
Fiscal year2015201620172018201920202021
Revenue$1.4M4$7.1M5$15.3M6$18.5M7$6.6M8$5.5M3$6.4M3
Cost of revenue$985.0K4$4.6M5$7.8M6$11.2M7$5.6M8$5.2M3$5.8M3
Gross profit$462.0K4$2.5M5$7.4M6$7.3M7$1.0M8$296.0K3$620.0K3
Research and development$5.0M4$8.4M5$12.3M6$13.6M7$8.6M8$5.1M3$9.7M3
Selling, general and admin$7.5M4$12.9M5$28.8M6$38.7M7$22.4M8$13.7M3$12.5M3
Operating expenses$22.2M3
Operating income-$12.0M4-$18.7M5-$33.7M6-$45.0M7-$30.7M8-$18.5M3-$21.6M3
Interest$415.0K4$1.4M5$3.2M6$4.4M7$4.4M8$910.0K3$1.0M3
Income before tax-$21.8M3
Income tax$06$07$08$03
Net income-$12.4M4-$20.1M5-$37.0M6-$50.0M7-$42.5M8-$21.9M3-$22.0M3

Compare VIVEVE MEDICAL, INC. with another company

Corporate structure

VIVEVE MEDICAL, INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of VIVEVE MEDICAL, INC.

  • Hudson Bay Capital Management LP Filed SC 13G/A on VIVEVE MEDICAL, INC., latest Feb 4, 2022
  • Empery Asset Management, LP Filed SC 13G/A on VIVEVE MEDICAL, INC., latest Jan 18, 2022
  • VIVEVE MEDICAL, INC. Englewood, Colorado

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What VIVEVE MEDICAL, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$4.3M3 Dec 31, 2021$5.7M3 Dec 31, 2020−24.5%
Accumulated depreciation$2.8M3 Dec 31, 2021$2.9M3 Dec 31, 2020−6.4%
Property and equipment, net$1.6M3 Dec 31, 2021$2.8M3 Dec 31, 2020−43.7%
Operating-lease assets (leased space)$130.0K8 Dec 31, 2020$395.0K8 Dec 31, 2019−67.1%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$19.2M3 Dec 31, 2021$6.5M3 Dec 31, 2020+193.8%
Stakes in other companies (equity method)$577.0K3 Dec 31, 2021$833.0K3 Dec 31, 2020−30.7%

Inventory

ItemLatestA year beforeChange
Inventory, total$1.5M3 Dec 31, 2021$3.3M3 Dec 31, 2020−54.8%
Raw materials$493.0K3 Dec 31, 2021$436.0K3 Dec 31, 2020+13.1%
Finished goods$979.0K3 Dec 31, 2021$2.8M3 Dec 31, 2020−65.3%

Leadership

Who has led VIVEVE MEDICAL, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Mark R. Tauscher2006–2013
  2. Patricia Scheller2014–2018
  3. Scott Durbin2018–2023

President

  1. Mark R. Tauscher2006–2013
  2. James G. Atkinson2015–2019

Chief financial officer

  1. James G. Thomasch2006–2009
  2. Gregory W. Mann2012–2013
  3. Scott Durbin2014–2018
2010201520202025
Board members and other officers (28)

Former names

  • PLC SYSTEMS INCMay 15, 1996 to Sep 19, 20142

Timeline

  1. Jan 18, 20238-K Listing notice or transfer43
  2. Jan 17, 20238-K Exit or restructuring costs; Listing notice or transfer; Other events44
  3. Dec 15, 20228-K Regulation FD disclosure45
  4. Dec 2, 20228-K Listing notice or transfer46
  5. Dec 1, 20228-K Regulation FD disclosure47
  6. Nov 23, 20228-K Listing notice or transfer48
  7. Nov 10, 20228-K Results of operations49
  8. Oct 4, 20228-K Regulation FD disclosure50
  9. Sep 27, 20228-K Regulation FD disclosure51
  10. Sep 22, 20228-K Regulation FD disclosure52
  11. Sep 15, 20228-K Regulation FD disclosure53
  12. Sep 1, 20228-K Regulation FD disclosure54
  13. May 15, 2018New chief executive Scott Durbin becomes CEO12
  14. Sep 25, 2014New chief executive Patricia Scheller becomes CEO13
  15. May 19, 2006New chief executive Mark R. Tauscher becomes CEO14

Calendar

When it reported results

  1. Nov 10, 2022Reported quarterly or annual results49
  2. Aug 11, 2022Reported quarterly or annual results55
  3. May 12, 2022Reported quarterly or annual results56
  4. Mar 17, 2022Reported quarterly or annual results57
  5. Nov 12, 2021Reported quarterly or annual results58

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

81 filings to the SEC since October 2021: 1 annual reports, 4 quarterly reports, 23 major events, 15 insider forms, 2 large holders, 1 private raises, 35 other. The latest 20:

  1. Feb 6, 202315-12G EDGAR
  2. Jan 30, 2023EFFECT EDGAR
  3. Jan 30, 2023EFFECT EDGAR
  4. Jan 30, 2023EFFECT EDGAR
  5. Jan 30, 2023EFFECT EDGAR
  6. Jan 30, 2023EFFECT EDGAR
  7. Jan 30, 2023EFFECT EDGAR
  8. Jan 30, 2023EFFECT EDGAR
  9. Jan 27, 2023RW EDGAR
  10. Jan 27, 2023POS AM EDGAR
  11. Jan 27, 2023POS AM EDGAR
  12. Jan 27, 2023POS AM EDGAR
  13. Jan 27, 2023POS AM EDGAR
  14. Jan 27, 2023POS AM EDGAR
  15. Jan 27, 2023POS AM EDGAR
  16. Jan 27, 2023POS AM EDGAR
  17. Jan 27, 2023S-8 POS EDGAR
  18. Jan 27, 2023S-8 POS EDGAR
  19. Jan 27, 2023S-8 POS EDGAR
  20. Jan 27, 2023S-8 POS EDGAR

The 81 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Oct 14, 2022Raised $14,675 in a private offering of equity Form D: 1 investor so far Form D

SEC filer profile

How VIVEVE MEDICAL, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARVIVEVE MEDICAL, INC.1
  • CIK0000879682
  • Employer ID (EIN)04-31538581
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3845 Electromedical & Electrotherapeutic Apparatus1
  • Business address345 Inverness Drive South, Building B, Suite 250, Englewood, CO 801121
  • Phone40853019001
  • Shares outstanding10,723,857 as of Nov 9, 202210
  • Public float$31.4M as of Jun 30, 20213
  • On EDGAR sinceFeb 6, 19961
  • Filings1,116 in all: 4 (281), 8-K (255), 10-Q (81), 424B3 (36), CORRESP (33), EFFECT (29), SC 13G/A (29), 3 (28)1
    All 53 form types

    10-K (26), DEF 14A (25), SC 13G (23), UPLOAD (22), POS AM (21), SC 13D/A (20), S-8 (18), S-8 POS (17), S-1/A (16), D (13), DEFA14A (13), 4/A (11), 424B2 (11), S-1 (11), 424B8 (10), 424B5 (9), S-3 (8), SC 13D (7), PRE 14A (6), ARS (5), S-3/A (5), 10-K/A (4), 424B4 (4), 3/A (3), 8-K/A (3), CT ORDER (3), PRER14A (3), S-1MEF (3), 25-NSE (2), DEFM14A (2), DEL AM (2), FWP (2), PREM14A (2), RW (2), SC TO-I/A (2), 15-12G (1), 5 (1), 8-A12B (1), 8-A12B/A (1), 8-A12G (1), CERTNAS (1), NT 10-K (1), PRES14A (1), S-3MEF (1), SC TO-I (1)

  • Latest filingsAnnual report (10-K) Mar 17, 2022
    Quarterly report (10-Q) Nov 10, 2022
    Proxy statement (DEF 14A) Mar 17, 2022
    Latest 8-K (8-K) Jan 18, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60